$2.72 Billion is the total value of DLD Asset Management, LP's 99 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 315.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | New | SPDR S&P 500 ETF TRput | $339,144,000 | – | 1,200,000 | +100.0% | 12.49% | – |
| Buy | MOLINA HEALTHCARE INCnote 1.125% 1/1 | $238,099,000 | +27.8% | 69,793,000 | +7.3% | 8.77% | -31.3% | |
| QCOM | Buy | QUALCOMM INCput | $179,445,000 | +54.0% | 3,146,500 | +53.7% | 6.61% | -17.2% |
| Buy | ADVANCED MICRO DEVICES INCnote 2.125% 9/0 | $165,152,000 | +49.4% | 50,486,000 | +11.1% | 6.08% | -19.7% | |
| ICPT | Buy | INTERCEPT PHARMACEUTICALS INput | $162,200,000 | +92.8% | 1,449,900 | +73.7% | 5.97% | +3.6% |
| AMGN | New | AMGEN INCput | $160,139,000 | – | 843,100 | +100.0% | 5.90% | – |
| New | WORLD WRESTLING ENTMT INCnote 3.375%12/1 | $150,689,000 | – | 42,500,000 | +100.0% | 5.55% | – | |
| Buy | SQUARE INCnote 0.375% 3/0 | $121,144,000 | +292.0% | 36,920,000 | +195.4% | 4.46% | +110.6% | |
| New | SAREPTA THERAPEUTICS INCdbcv 1.500%11/1 | $115,720,000 | – | 64,000,000 | +100.0% | 4.26% | – | |
| BIIB | New | BIOGEN INC | $81,953,000 | – | 346,700 | +100.0% | 3.02% | – |
| BIIB | New | BIOGEN INCput | $81,956,000 | – | 346,800 | +100.0% | 3.02% | – |
| MDCO | Buy | MEDICINES COput | $65,258,000 | +135.8% | 2,334,800 | +61.4% | 2.40% | +26.7% |
| QCOM | New | QUALCOMM INCcall | $61,182,000 | – | 1,072,800 | +100.0% | 2.25% | – |
| AMGN | New | AMGEN INC | $53,236,000 | – | 280,220 | +100.0% | 1.96% | – |
| LLL | Buy | L3 TECHNOLOGIES INC | $46,652,000 | +52.6% | 226,058 | +28.4% | 1.72% | -18.0% |
| ABBV | New | ABBVIE INCput | $40,295,000 | – | 500,000 | +100.0% | 1.48% | – |
| CELG | New | CELGENE CORP | $33,019,000 | – | 350,000 | +100.0% | 1.22% | – |
| RHT | Buy | RED HAT INC | $31,059,000 | +14.1% | 170,000 | +9.7% | 1.14% | -38.7% |
| FDC | New | FIRST DATA CORP NEW | $30,211,000 | – | 1,150,000 | +100.0% | 1.11% | – |
| New | MEDICINES COnote 2.750% 7/1 | $29,998,000 | – | 35,500,000 | +100.0% | 1.10% | – | |
| ULTI | New | ULTIMATE SOFTWARE GROUP INC | $23,109,000 | – | 70,000 | +100.0% | 0.85% | – |
| BBT | New | BB&T CORP | $22,088,000 | – | 474,695 | +100.0% | 0.81% | – |
| New | RETROPHIN INCnote 2.500% 9/1 | $19,830,000 | – | 21,006,000 | +100.0% | 0.73% | – | |
| AABA | Buy | ALTABA INC | $18,530,000 | +76.3% | 250,000 | +37.8% | 0.68% | -5.3% |
| USG | Buy | U S G CORP | $18,186,000 | +7.3% | 420,000 | +5.7% | 0.67% | -42.3% |
| Buy | HORIZON PHARMA INVT LTDnote 2.500% 3/1 | $15,339,000 | +241.6% | 13,500,000 | +200.0% | 0.56% | +83.4% | |
| ONCE | New | SPARK THERAPEUTICS INC | $14,804,000 | – | 130,000 | +100.0% | 0.54% | – |
| BMY | New | BRISTOL MYERS SQUIBB COcall | $14,316,000 | – | 300,000 | +100.0% | 0.53% | – |
| GG | New | GOLDCORP INC NEW | $13,728,000 | – | 1,200,000 | +100.0% | 0.51% | – |
| WP | New | WORLDPAY INCcl a | $11,849,000 | – | 104,400 | +100.0% | 0.44% | – |
| ATTU | New | ATTUNITY LTD | $10,553,000 | – | 450,000 | +100.0% | 0.39% | – |
| OAK | New | OAKTREE CAP GROUP LLCunit cl a | $10,129,000 | – | 204,000 | +100.0% | 0.37% | – |
| LEXEA | New | LIBERTY EXPEDIA HLDGS INC | $10,058,000 | – | 235,000 | +100.0% | 0.37% | – |
| MLNX | New | MELLANOX TECHNOLOGIES LTD | $8,285,000 | – | 70,000 | +100.0% | 0.30% | – |
| LBTYA | Buy | LIBERTY GLOBAL PLC | $7,476,000 | +29.9% | 300,000 | +11.2% | 0.28% | -30.4% |
| CARA | New | CARA THERAPEUTICS INCcall | $6,927,000 | – | 352,700 | +100.0% | 0.26% | – |
| New | HERBALIFE LTDnote 2.000% 8/1 | $6,232,000 | – | 5,000,000 | +100.0% | 0.23% | – | |
| RTRX | New | RETROPHIN INCput | $6,008,000 | – | 265,600 | +100.0% | 0.22% | – |
| ANTM | New | ANTHEM INCput | $5,740,000 | – | 20,000 | +100.0% | 0.21% | – |
| NITE | New | NIGHTSTAR THERAPEUTICS PLCadr | $4,594,000 | – | 181,075 | +100.0% | 0.17% | – |
| ELLI | New | ELLIE MAE INC | $4,237,000 | – | 42,935 | +100.0% | 0.16% | – |
| SIFI | Buy | SI FINL GROUP INC MD | $4,176,000 | +14.6% | 323,436 | +13.0% | 0.15% | -38.4% |
| IMDZ | New | IMMUNE DESIGN CORP | $3,510,000 | – | 600,030 | +100.0% | 0.13% | – |
| WBC | New | WABCO HLDGS INC | $3,442,000 | – | 26,112 | +100.0% | 0.13% | – |
| IMGN | New | IMMUNOGEN INCput | $3,347,000 | – | 1,239,500 | +100.0% | 0.12% | – |
| IMGN | New | IMMUNOGEN INC | $3,215,000 | – | 1,186,300 | +100.0% | 0.12% | – |
| FOXA | New | FOX CORP | $3,023,000 | – | 82,349 | +100.0% | 0.11% | – |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $2,967,000 | +234.9% | 33,400 | +221.2% | 0.11% | +78.7% |
| BCRX | New | BIOCRYST PHARMACEUTICALSput | $2,927,000 | – | 359,600 | +100.0% | 0.11% | – |
| BCRX | New | BIOCRYST PHARMACEUTICALScall | $2,896,000 | – | 355,800 | +100.0% | 0.11% | – |
| TIER | New | TIER REIT INC | $2,866,000 | – | 100,000 | +100.0% | 0.11% | – |
| UA | New | UNDER ARMOUR INCcl c | $2,831,000 | – | 150,000 | +100.0% | 0.10% | – |
| DIS | New | DISNEY WALT CO | $2,759,000 | – | 24,845 | +100.0% | 0.10% | – |
| WCG | New | WELLCARE HEALTH PLANS INC | $2,698,000 | – | 10,000 | +100.0% | 0.10% | – |
| BMRN | New | BIOMARIN PHARMACEUTICAL INCput | $2,442,000 | – | 27,500 | +100.0% | 0.09% | – |
| New | ZENDESK INCnote 0.250% 3/1 | $2,190,000 | – | 1,500,000 | +100.0% | 0.08% | – | |
| BKNG | New | BOOKING HLDGS INC | $2,094,000 | – | 1,200 | +100.0% | 0.08% | – |
| VSM | New | VERSUM MATLS INC | $2,012,000 | – | 40,000 | +100.0% | 0.07% | – |
| OSIR | New | OSIRIS THERAPEUTICS INC NEW | $1,900,000 | – | 100,000 | +100.0% | 0.07% | – |
| ATEX | Buy | PDVWIRELESS INC | $1,846,000 | +97.4% | 52,500 | +110.0% | 0.07% | +6.2% |
| BKNG | New | BOOKING HLDGS INCput | $1,745,000 | – | 1,000 | +100.0% | 0.06% | – |
| AMRN | New | AMARIN CORP PLCspons adr new | $1,453,000 | – | 70,000 | +100.0% | 0.05% | – |
| ENTX | Buy | ENTERA BIO LTD | $1,436,000 | +54.2% | 332,026 | +8.8% | 0.05% | -17.2% |
| SXCP | New | SUNCOKE ENERGY PARTNERS L P | $1,245,000 | – | 100,000 | +100.0% | 0.05% | – |
| CNAT | Buy | CONATUS PHARMACEUTICALS INCcall | $1,113,000 | -26.9% | 1,030,200 | +17.1% | 0.04% | -60.6% |
| ALDX | New | ALDEYRA THERAPEUTICS INCput | $1,057,000 | – | 117,300 | +100.0% | 0.04% | – |
| CZR | New | CAESARS ENTMT CORPcall | $870,000 | – | 100,000 | +100.0% | 0.03% | – |
| EEFT | New | EURONET WORLDWIDE INC | $642,000 | – | 4,500 | +100.0% | 0.02% | – |
| RIG | New | TRANSOCEAN LTD | $636,000 | – | 73,000 | +100.0% | 0.02% | – |
| LABL | New | MULTI COLOR CORPput | $599,000 | – | 12,000 | +100.0% | 0.02% | – |
| New | HERBALIFE LTDput | $583,000 | – | 11,000 | +100.0% | 0.02% | – | |
| ENTG | New | ENTEGRIS INC | $535,000 | – | 15,000 | +100.0% | 0.02% | – |
| NVAX | Buy | NOVAVAX INCcall | $531,000 | +22.6% | 964,100 | +308.0% | 0.02% | -33.3% |
| GCVRZ | Buy | SANOFIright 12/31/2020 | $293,000 | +3.9% | 644,000 | +7.2% | 0.01% | -42.1% |
| CHK | New | CHESAPEAKE ENERGY CORP | $308,000 | – | 99,200 | +100.0% | 0.01% | – |
| BIOS | New | BIOSCRIP INC | $300,000 | – | 150,000 | +100.0% | 0.01% | – |
| ENTXW | New | ENTERA BIO LTDcall | $279,000 | – | 310,023 | +100.0% | 0.01% | – |
| IMGN | New | IMMUNOGEN INCcall | $270,000 | – | 100,000 | +100.0% | 0.01% | – |
| PTI | New | PROTEOSTASIS THERAPEUTICS INcall | $64,000 | – | 50,000 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TELEPHONE & DATA SYS INC | 18 | Q2 2023 | 0.5% |
| WORLD WRESTLING ENTMT INC | 17 | Q1 2023 | 6.3% |
| BOOKING HOLDINGS INC | 15 | Q4 2022 | 1.2% |
| LIBERTY MEDIA CORP DELAWARE | 14 | Q4 2022 | 7.5% |
| WAYFAIR INC | 14 | Q3 2023 | 3.2% |
| DISCOVERY INC | 14 | Q2 2021 | 1.9% |
| BOOKING HOLDINGS INC | 14 | Q4 2022 | 0.9% |
| GENWORTH FINL INC | 14 | Q3 2023 | 0.3% |
| GUESS INC | 13 | Q3 2023 | 2.8% |
| LIBERTY GLOBAL PLC | 13 | Q2 2021 | 0.8% |
View DLD Asset Management, LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-12 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR/A | 2022-02-22 |
View DLD Asset Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.